Outcome of Investors/Analysts Meeting held on August 10, 2026

Date: August 12, 2026 Department of Corporate Services, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400001 Scrip Code: 539997 Sub: Outcome of Investors / Analysts Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir / Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that a Knowledge Session (Virtual Interaction) for Investors, organized by Go India Advisors on behalf of the Company, was held on Monday, 10th August, 2026 at 4:00 P.M. (IST). During the said interaction, the management discussed the Company’s business operations, performance, and outlook, by referring to publicly available information only. No unpublished price sensitive information (UPSI) was shared or discussed during the meeting. The link to access the said audio/video recording is: https://www.kwalitypharma.com/Schedule%20of%20Analysts%20or%20Institutional%20Investors%20meet%20and%20Presentations%20made%20to%20them.php This is for your information and records For Kwality Pharmaceuticals Limited Ramesh Kumar Managing Director DIN:00462656